Patoloxía Molecular das Doenzas Raras
PatMol-DR
Centro de Investigación Biomédica en Red sobre Epidemiología Y Salud Pública
Madrid, EspañaPublicacións en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Epidemiología Y Salud Pública (6)
2023
-
Differences in weight loss and safety between the glucagon-like peptide-1 receptor agonists: A non-randomized multicenter study from the titration phase
Primary Care Diabetes, Vol. 17, Núm. 4, pp. 366-372
-
Effect of dapagliflozin on COVID-19 infection and risk of hospitalization
The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2335-2342
2021
-
Evaluation of the impact of an integrated care pathway for pulmonary embolism: A quasi-experimental pre-post study
Journal of Thoracic Disease, Vol. 13, Núm. 9, pp. 5373-5382
2012
-
Evolution of target organ damage by different values of self-blood pressure measurement in untreated hypertensive patients
American Journal of Hypertension, Vol. 25, Núm. 12, pp. 1256-1263
2010
-
Do GRACE (Global Registry of Acute Coronary events) risk scores still maintain their performance for predicting mortality in the era of contemporary management of acute coronary syndromes?
American Heart Journal, Vol. 160, Núm. 5
-
Evaluating the performance of the can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA les (CRUSADE) bleeding score in a contemporary Spanish cohort of patients with Non-ST-Segment elevation acute myocardial infarction
Circulation, Vol. 121, Núm. 22, pp. 2419-2426